key: cord-0063747-l67vl1yn
authors: Singh, Director and Head Anaesthesia and Critical Care, CLBS Dr Shweta A.; Khurana, Fellow Dr Saurabh; Jadaun, Consultant Dr Shekhar Singh; Gupta, Chairman, CLBS Dr Subhash; Saigal, Principal Director & Head, Hepatology and Liver Transplant Medicine Dr Sanjiv
title: “Strategies of liver transplantation during the second wave - based on lessons learnt from the first wave of the SARS- COV2 pandemic”
date: 2021-05-27
journal: nan
DOI: 10.1016/j.liver.2021.100015
sha: 8e6e0d4573473bdd836ce6d40b523718e6590234
doc_id: 63747
cord_uid: l67vl1yn

nan

During this period, mandatory testing for SARS -COV2 was done prior to hospitalisation as well as prior to undertaking surgery. Several urgent transplants were deferred when their asymptomatic donors incidentally tested COVID RT-PCR positive on pre-operative evaluation.

After two weeks of quarantine and two weeks of additional observation and evaluation for post COVID sequelae the surgeries were rescheduled. One of these was a young girl with Caroli's disease with decompensated liver failure, prepared for ABO incompatible LDLT with induction therapy (rituximab) followed by plasmapheresis. A day prior to surgery, her donor (sister), During the first wave of SARS-CoV-2 infection, immunosuppression had seemed to be protective against severe COVID-19 and mortality in transplant recipients. A higher mortality was seen with advanced age and comorbidities in these patients. (7) As pandemic is continuing our understanding of COVID-19 in transplant recipients and protective response of vaccination is still evolving and should improve with time.

Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI)

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question

AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease

ACIP General Best Practice Guidelines for Immunization | CDC

Preexisting liver disease is associated with poor outcome in patients with SARS CoV2 infection

The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study